Glen Cove Hospital

Details

Name :

Glen Cove Hospital

Address  :

101 St. Andrews Lane

Town  :

Glen Cove

State  :

New York

Country  :

USA

Post Code:

11542 2254

Phone  :

516 674 7300

Web URL  :

Specialization
  • Cardiology
  • Neurologist
  • Orthopedics
  • Pulmonology
Facilities

Total Number Of Beds : 265


Description

Outstanding scores in patient satisfaction along with a comprehensive service excellence program highlight Glen Cove Hospital The 265bed hospital provides excellent medical and surgical care

The hospital is home to the internationally known Orthopaedic amp Rehabilitation Institute that features stateoftheart programs in joint replacement and an allinclusive spine program as well as rehabilitative treatment in orthopaedics neurology pulmonary medicine cardiology and generalized debilitation resulting from chronic illness The hospital also boasts the Family Practice Residency Program which has trained primary care physicians from throughout the United States The geriatric unit treats older adults for a full spectrum of health problems Community House a division of Substance Abuse Services at Glen Cove Hospital provides inpatient and outpatient services with some of the latest treatment options for psychological and substance abuse problems

Our Emergency Department was recently ranked as one of the best in patient satisfaction among hospitals nationwide according to Press Ganey Associates the healthcare industrys leading independent vendor of satisfaction measurement and improvement services
Christiana Care Health System Skanska USA Top Out 215M Wilmington DE Hospital

Christiana Care Health System commemorated the structural completion of its new Wilmington Hospital during a topping out ceremony on Thursday April 12 on the top floor of the public parking garage on the hospitals campus The 215 million expansion includes a 386000squarefoot facility with a 10story patient tower and plaza that will feature new me... Read More

Group B Neisseria meningitidis Vaccine Shows Promise

An investigational vaccine may represent a strong lead in the fight against group B Neisseria meningitidis according to results of a phase 2 study published online in the Lancet Administered in 3 doses over the course of 6 months a new bivalent vaccine was well tolerated and induced a strong immune response against multiple strains of the poten... Read More